Technical Analysis for PARNF - Parnell Pharmaceuticals Holdings Ltd.

Grade Last Price % Change Price Change
F 0.0002 100.00% 0.0001
PARNF closed up 100.0 percent on Friday, January 14, 2022, on 1 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical PARNF trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Stochastic Buy Signal Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 100.00%
Stochastic Buy Signal Bullish 100.00%
Narrow Range Bar Range Contraction 100.00%
Wide Bands Range Expansion 100.00%
Older End-of-Day Signals for PARNF ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Parnell Pharmaceuticals Holdings Ltd. Description

Parnell Pharmaceuticals Holdings Limited is a veterinary pharmaceutical company. The Company is focused on developing, manufacturing and commercializing animal health solutions. The principal activities of the Company include manufacture for global sale of animal pharmaceutical product, and research and development of pharmaceutical products for global animal health markets. The Company operates through four segments: Companion Animal, Production Animal-U.S., Production Animal-Rest of World and Manufacturing Operations. It augments its pharmaceutical products with its FETCH and mySYNCH software platforms. It offers disease-modifying product, Zydax, for the treatment of osteoarthritis (OA). Its reproductive hormone products include estroPLAN and GONAbreed. It has a nutraceutical product, Glyde. It also markets a non-steroidal anti-inflammatory drug (NSAID), called Tergive. It is developing a pipeline of clinical drug candidates, such as PAR 121, PAR 122, PAR 101, PAR 081 and PAR 061.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Health Pharmaceutical Industry Pharmacy Pharmaceutical Products Pharmacology Arthritis Nutraceutical Software Platform Hormone Osteoarthritis Companion Nutraceutical Product Manufacturing Operations Dax Health Solutions Software Platforms Steroid Veterinary Pharmaceutical Treatment Of Osteoarthritis

Is PARNF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 0.89
52 Week Low 0.0001
Average Volume 8,917
200-Day Moving Average 0.2582
50-Day Moving Average 0.1630
20-Day Moving Average 0.0563
10-Day Moving Average 0.0081
Average True Range 0.0205
ADX 15.05
+DI 37.3477
-DI 43.7522
Chandelier Exit (Long, 3 ATRs) 0.1882
Chandelier Exit (Short, 3 ATRs) 0.0616
Upper Bollinger Bands 0.1744
Lower Bollinger Band -0.0618
Percent B (%b) 0.26
BandWidth 419.5382
MACD Line -0.0514
MACD Signal Line -0.0508
MACD Histogram -0.0005
Fundamentals Value
Market Cap 3.63 Thousand
Num Shares 18.1 Million
EPS -1.05
Price-to-Earnings (P/E) Ratio 0.00
Price-to-Sales 0.27
Price-to-Book 0.00
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0002
Resistance 3 (R3) 0.0002 0.0002 0.0002
Resistance 2 (R2) 0.0002 0.0002 0.0002 0.0002
Resistance 1 (R1) 0.0002 0.0002 0.0002 0.0002 0.0002
Pivot Point 0.0002 0.0002 0.0002 0.0002 0.0002
Support 1 (S1) 0.0002 0.0002 0.0002 0.0002 0.0002
Support 2 (S2) 0.0002 0.0002 0.0002 0.0002
Support 3 (S3) 0.0002 0.0002 0.0002
Support 4 (S4) 0.0002